Stille AB: Interim Report Q2 2024
Stille AB (publ) today presents the report for the second quarter and first half of the year 2024.
Revenue amounted to MSEK 142.6 (75.1) driven by strong organic growth in surgical instruments and the acquisition of Fehling. Total growth amounted to 89.9 percent, of which 7.4 percent was organic growth.
“It is encouraging to see that organic growth remains robust, despite strong comparable figures.”, says Torbjörn Sköld and continues, “We are particularly pleased with the continued successful integration of Fehling and that our continual efforts
to improve our pricing, purchasing, production and quality are having a positive effect on our operations.”
The gross profit amounted to 49.3 percent (44.6) and operating profit before one-time costs amounted to MSEK 29.1 (11.9).
”2024 has continued on a high note – our products are delivering value to our customers, which is creating favorable demand, strong growth and a healthy cash flow.”, concludes Stille’s CEO.
| MSEK | APR-JUN 2024 | APR-JUN 2023 | JAN-JUN 2024 | JAN-JUN 2023 | JUL-JUN 2023/24 | JAN-DEC 2023 |
| Net sales | 142.6 | 75.1 | 282.3 | 147.5 | 429.7 | 294.9 |
| Gross profit, % | 49.3 | 44.6 | 48.9 | 43.5 | 50.2 | 44.8 |
| EBITDA before non-recurring items | 36.0 | 15.7 | 69.6 | 29.4 | 102.8 | 62.6 |
| EBITDA before non-recurring items, % | 25.2 | 20.9 | 24.7 | 20.0 | 23.9 | 21.2 |
| EBITDA | 32.6 | 15.7 | 49.6 | 26.1 | 82.8 | 59.3 |
| EBITDA, % | 22.9 | 20.9 | 17.6 | 17.7 | 20.0 | 20.1 |
| Operating profit before non-recurring items | 29.1 | 11.9 | 56.1 | 22.4 | 81.9 | 48.3 |
| Operating profit before non-recurring items, % | 20.4 | 15.9 | 19.9 | 15.2 | 21.0 | 16.4 |
| Operating profit | 25.7 | 11.9 | 36.0 | 19.1 | 61.9 | 45.0 |
| Operating profit, % | 18.0 | 15.9 | 12.8 | 12.9 | 15.1 | 15.2 |
Torshälla, July 18th, 2024.